doi: 10.1161/hs0202.102880
(Stroke. 2002;33:629.)
© 2002 American Heart Association, Inc.
Comments, Opinions, and Reviews |
Costs and Benefits of Carotid Endarterectomy and Associated Preoperative Arterial Imaging
A Systematic Review of Health Economic Literature
From the Department of Public Health Sciences, Medical School, University of Edinburgh, and the Department of Clinical Neurosciences, University of Edinburgh, Western General Hospital, Edinburgh, Scotland, United Kingdom.
Correspondence to Marikie Benade, 403 Lanark Road, Colinton, Edinburgh EH13 0NQ, Scotland, United Kingdom. E-mail mtreadwell{at}barclays.net
Background and Purpose— Carotid endarterectomy (CEA) reduces the risk of stroke in patients with severe stenosis of the internal carotid artery. However, the cost implications of this procedure have not yet been satisfactorily addressed. The objective of this systematic review was to critically appraise the studies addressing the economic implications of CEA and the associated preoperative arterial imaging.
Methods— A systematic search strategy was developed to identify research articles related to the economic evaluation of CEA and the associated preoperative imaging. MEDLINE, EMBASE, and BIOSIS were electronically searched, and reference lists from identified studies were searched manually. Methods used to critically appraise these studies followed proposed guidelines for an economic evaluation that addresses 10 distinct aspects under 3 separate headings.
Results— Studies identified were either partial economic or full economic evaluations, with the majority coming from the United States. The methodological quality seems to have improved over time. The studies that assessed cost-effectiveness of CEA were all modeling studies; although the same baseline parameters were used, divergent conclusions were reached. Variation in the cost estimates of CEA ($9500 to $11 500) in the same health care system was also observed in the studies reporting only on the cost of carotid surgery. For a symptomatic patient, the benefit of CEA ranged from 0.35 quality adjusted life years (QALYs) (4.2 months) at a cost of $4100 per QALY to 0.93 QALYs (11.2 months) at a cost of $434 per QALY. For an asymptomatic patient, the cost-effectiveness of CEA varied from 0.15 QALYs (1.8 months) at a cost of $52 700 per QALY to 0.25 QALYs (3 months) at a cost of $8004 per QALY.
Conclusions— Divergent conclusions of the cost-effectiveness of CEA were reported from studies that addressed the same questions and using similar parameters in their models. The cost estimates of the procedure and the different time periods used in the studies might explain these inconsistencies. Modeling studies in hypothetical cohorts might also be to blame. The cost-effectiveness of CEA will only definitively be assessed when real patient data are used.
Key Words: carotid endarterectomy • cost-benefit analysis • costs and costs analysis • preoperative arterial imaging • structured review
This article has been cited by other articles:
 |
|
 |
|
  R. Luengo-Fernandez, A. M. Gray, and P. M. Rothwell Costs of Stroke Using Patient-Level Data: A Critical Review of the Literature Stroke, February 1, 2009; 40(2): e18 - e23. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. F. Meschia, T. G. Brott, and R. W. Hobson II Diagnosis and Invasive Management of Carotid Atherosclerotic Stenosis Mayo Clin. Proc., July 1, 2007; 82(7): 851 - 858. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Pignone, S. Saha, T. Hoerger, K. N. Lohr, S. Teutsch, and J. Mandelblatt Challenges in Systematic Reviews of Economic Analyses Ann Intern Med, June 21, 2005; 142(12_Part_2): 1073 - 1079. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Kedikoglou, M. Belechri, X. Dedoukou, T. Spyridopoulos, D.-M. Alexe, E. Pappa, A. Stamou, and E. Petridou A maternity hospital-based infant car-restraint loan scheme: Public health and economic evaluation of an intervention for the reduction of road traffic injuries Scand J Public Health, January 1, 2005; 33(1): 42 - 49. [Abstract] [PDF]
|
|
|
|
 |
|
 P A G Sandercock Should I start all my ischaemic stroke and TIA patients on a statin, an ACE inhibitor, a diuretic, and aspirin today? J. Neurol. Neurosurg. Psychiatry, November 1, 2003; 74(11): 1461 - 1464. [Full Text] [PDF]
|
|
|
|
|
|
D. B. Matchar Health Policy in Stroke: Translating What We Know Into What We Do Stroke, February 1, 2003; 34(2): 370 - 371. [Full Text] [PDF]
|
|
|
|
 |
|
 P. J. Nederkoorn, Y. van der Graaf, B. C. Eikelboom, A. van der Lugt, L. W. Bartels, and W. P.T.M. Mali Time-of-Flight MR Angiography of Carotid Artery Stenosis: Does a Flow Void Represent Severe Stenosis? AJNR Am. J. Neuroradiol., November 1, 2002; 23(10): 1779 - 1784. [Abstract] [Full Text] [PDF]
|
|